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Abstract The discovery of life extension in Cae-
norhabditis elegans treated with anticonvulsant med-
ications has raised the question whether these drugs
are prospective anti-aging candidate compounds. The
impact of these compounds on neural modulation
suggests that they might inﬂuence the chronic
diseases of aging as well. Lamotrigine is a commonly
used anticonvulsant with a relatively good adverse-
effects proﬁle. In this study, we evaluated the
interaction between the impacts of lamotrigine on
mortality rate, lifespan, metabolic rate and locomo-
tion. It has been proposed in a wide range of animal
models that there is an inverse relationship between
longevity, metabolic rate, and locomotion. We
hypothesized that the survival beneﬁts displayed by
this compound would be associated with deleteri-
ous effects on health span, such as depression of
locomotion. Using Drosophila as our model system,
we found that lamotrigine decreased mortality and
increased lifespan in parallel with a reduction in
locomotor activity and a trend towards metabolic rate
depression. Our ﬁndings underscore the view that
assessing health span is critical in the pursuit of
useful anti-aging compounds.
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Introduction
Mutations in genes such as age-1 (Arking 1998), daf-
2 (Kenyon et al. 1993; Kimura et al. 1997), Indy
(Rogina et al. 2000), and chico (Clancy et al. 2001)
have been found to increase life span in the labora-
tory organisms Caenorhabditis elegans and Drosoph-
ila melanogaster. Genetic manipulations offer helpful
clues in identifying pathways for pharmacological
interventions, but there is the possibility that these
genetic manipulations result in adverse metabolic
effects. In particular, there is the possibility that
‘‘longevity mutants’’ increase lifespan only because
of a ‘‘refrigeration’’ effect. The ‘‘refrigeration’’ effect
refers by analogy to the phenomenon in which an
increase in lifespan is seen at environmentally low
temperatures due to decreases in metabolic rate
(Van Voorhies et al. 2006). The inverse correlation
between metabolic rate and longevity in Drosophila
has been reported in a number of studies. It has been
suggested that poikilotherms can have their lifespan
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decreased or increased, respectively (Finch 1990;
Rose 1991). In a recent study, Van Voorhies et al.
(2008) evaluated CO2 production in a large set of
recombinant inbred Drosophila males at various
ages. Although they reported a wide range of longevi-
ties and metabolic rates, no correlations between the
two variables were observed. This contrasts with
earlier experimental results, suggesting signiﬁcant
complexity in the relationship between lifespan and
metabolic rate. As humans are homeotherms with a
fairly stable metabolic rate, drugs that act via
substantial lowering of metabolic rate, thus producing
hypo metabolic syndromes, may not be appropriate
candidates for anti-aging interventions. Poikilother-
mic animal models, such as C. elegans and Drosoph-
ila, have the ability to tolerate metabolic rate
depression well during phases of poor environmental
conditions or deprivation of nutrients (Klass et al.
1983; Van Voorhies and Ward 1999). Since humans
do not posses the same capacity to endure such
depression of their metabolism, it is necessary to
evaluate metabolic rate as a confounding factor;
especially when considering results that might be
extrapolated to the clinical context.
Other potential confounds, such as fecundity
depression, can also result in lifespan extension.
These factors should also be evaluated during an anti-
aging substance screening process (Jafari and Rose
2006). Some compounds may increase lifespan
simply by substantially depressing fecundity; a
substantial depression in fecundity alone is sufﬁcient
to increase longevity in Drosophila (Smith 1959). In
order to ensure that the inferred anti-aging properties
are a direct effect of the compound, and not adverse
physiological changes, we need to assess the impact
of the compound on other aspects of the organism’s
physiology. A number of studies in the anti-aging
literature have addressed such secondary effects by
evaluating the impact of the proposed anti-aging
compound on fecundity and metabolic rate (Kang
et al. 2002; Jafari et al. 2007a, b, 2008). For instance,
Rhodiola rosea increased Drosophila lifespan at
certain doses but the fecundity was also reduced at
those doses (Jafari et al. 2007a). Therefore, a
fecundity assay is an important check for artifactual
lifespan enhancement.
In addition to checking for the impact of com-
pounds on physiological confounds of aging, we
should also evaluate their effect on biomarkers of
health span such as locomotor activity. In 1987, Le
Bourg reported an association between locomotor
activity and longevity in Drosophila. He showed that
spontaneous locomotor activity declined in females
as they aged and increased in males up to week ﬁve
and then began to decrease (Le Bourg 1987). In
another recent study, locomotion declined with aging
in Drosophila although males performed better than
females at advanced age (Simon et al. 2006).
Our study evaluated the impact of lamotrigine on
lifespan, physiological confounds of aging, and
health span of D. melanogaster. Although the mech-
anism of action of lamotrigine has yet to be fully
understood, it is believed that the drug primarily
targets voltage-sensitive sodium channels that inhibit
neural excitation through the repression of the
neurotransmitters glutamate and aspartate (Lang
et al. 1993). These neurotransmitters play key roles
in numerous physiological activities of various spe-
cies (Rock 1968; Fagg and Foster 1983; Wroblewski
and Danysz 1989; Advokat and Pellegrin 1992;
Navarro et al. 1998; Burton and Kazemi 2000).
Drosophila possesses glutamate neurotransmitters
that are regulated by sodium channels in their
nervous system. Studies conducted on the anesthetic
drug isoﬂurane have shown that Drosophila larvae
exhibited decreased glutamate neurotransmitter
release when treated with the drug. This decrease in
neuronal ﬁring is paralleled with a sedative phase
where decreased locomotor activity was observed
(Sandstrom 2004), suggesting a conserved neuronal
physiology shared by vertebrates and arthropods.
Due to lamotrigine inhibitory actions on the
glutamate neurotransmitter and Drosophila’s con-
served neural physiology with respect to the gluta-
mate receptor, relative to mammals, we hypothesized
that a depression of metabolic rate and locomotor
activity would be observed in ﬂies supplemented with
the drug.
Materials and methods
Drosophila population employed
All D. melanogaster stocks used in these experiments
were ultimately derived from a sample (called ‘‘IV’’)
of the Amherst, Massachusetts, Ives population that
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123was collected in 1975 and cultured at moderate to
large population sizes ever since (Rose et al. 1984).
This population has been reared at controlled densi-
ties (50–80 eggs per vial) for more than 700
generations with discrete generations cultured every
2 weeks.
Drug administration
Fruitﬂiesweresupplementedwithlamotrigine(Glaxo-
SmithKline)at1,3,6,12,24,and48 mg/ml,alongside
controls that were handled in the same manner but not
exposed to lamotrigine. These doses reﬂect the ﬁnal
concentrationoflamotrigineintheyeastpastethatwas
supplemented to adult ﬂies during the experiment.
Stock solutions were prepared by dissolving lamotri-
gine powder in water.
Mortality assay
All ﬂies used in these assays were raised as larvae in
5 ml of standard banana-molasses food at densities
between 50 and 80 eggs per 8-dram vial. Populations
were maintained at about 25C with constant illumi-
nation. During the assays, adults were kept in
standard 8-dram vials containing 5 ml of banana-
molasses food and coated with 75 ll of the drug-
yeast paste mixture. Adults were transferred to fresh
vials and survivors were counted every 2 days over a
28 day period. For each dose, 320 males and 320
females were exposed to the compound. There were 4
males and 4 females in each vial, with a total of 80
vials per dose per sex, and the ﬂies were transferred
every other day during the aging phase (4 weeks for
IV stocks). Data were analyzed by examining the
number of surviving ﬂies at the end of week four. The
statistical evaluation at the end of week four is based
on data accumulated from the records of survi-
vors obtained every 2 days. Signiﬁcant differences
between the control and each drug treatment were
assessed using the Pearson chi-square test. Mortality
assays were replicated for doses that decreased the
mortality rate. These doses were subsequently used in
the lifespan assay.
Lifespan assay
One hundred sixty male and 160 female ﬂies were
exposed to 0, 6, or 12 mg/ml of lamotrigine. There
were 4 males and 4 females in each vial, with a total
of 40 vials for each treatment. Survivorship was
determined with every other day transfers until every
ﬂy was dead. A one-way ANOVA and Dunn’s
multiple comparison tests versus control were used
to determine if there were signiﬁcant differences in
mean lifespan between the ﬂies given lamotrigine and
the control ﬂies. Additionally, to test for signiﬁcant
differences in maximum lifespan a one-way ANOVA
and Dunn’s multiple comparison tests versus control
were performed using the mean lifespan of the
longest-lived ten percent.
Metabolic rate assay
Control and treated ﬂies were reared for a 10-day
period in a similar fashion to that of the mortality
assay, as noted above. On day 11, ﬂies were
transferred into sex-speciﬁc vials containing their
respective dosages of lamotrigine. There were 6 vials
per dosage, each containing 4 ﬂies. Metabolic rate
was evaluated using the Licor LI-6260 gas analyzer.
CO2 production in treated ﬂies was compared to that
of the control group handled and assayed in parallel.
A ﬂow-through respirometer was used to measure the
rate of CO2 release from groups of ﬂies following the
methods of Williams et al. (2004). Room air was
passed through a small chamber containing soda
lime, two silica gel chambers, and a Drierite/Ascarite/
Drierite column. This produced a stream of CO2
-
free air that was forwarded into the chambers of the
ﬂies being measured at a rate of 100 ml/min. The air
was directed by a series of computer-controlled
valves (Sable Systems, Las Vegas, NV, USA) that
allowed separate chambers to be measured in turn.
The vials were assayed in a random sequence,
allowing for a sampling which was unbiased to
temporal and environmental conditions. CO2 levels
were averaged and recorded every second using the
data acquisition software DATACAN V (Sable
Systems). Each vial was measured for 20 min.
During periods when they were not being measured,
the ﬂies were kept in a ﬂow of dry, CO2-free air by
ﬂushing with a separate air stream. The last 5 min of
each 20 min recording of CO2 release was averaged
to provide an estimate of relative metabolic rate. The
effects of drug treatments on metabolic rates were
analyzed with a one-way ANOVA using drug level
treated as a ﬁxed effect.
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Locomotion studies were conducted to assess the
effects of lamotrigine on Drosophila locomotor
activity at week one and four of age. Male and
female ﬂies were exposed to 0, 6, or 12 mg/ml of
lamotrigine and tested for locomotor activity using
the automated Drosophila activity monitor DAM2
(Trikinetics, MA). After 1 and 4 weeks of lamotri-
gine exposure ﬂies were lightly anesthetized for the
purpose of sex classiﬁcation and to be transferred into
the 5 mm tubes needed for the DAM2 system. To
avoid CO2-dependent reductions in locomotor activ-
ity as well as to control for any new stimulus that may
affect activity, ﬂies were given a 30-min acclimation
period prior to be placed in the channels of the
monitor. Following the acclimation period data were
collected for individual ﬂies at 30-s intervals for a
45-minperiodresultinginatotalof90readingsperﬂy.
Any animal with a reading that exceeded the
population mean by two SD at any given 30-s interval
was excluded from that interval statistical analysis, as
abnormally high numbers in activity may have
resulted from activity that was localized to the
detector beam region. Any animals that had a total
number of movements less than two SD from the
population mean were excluded, since scores of zero
could be due to deaths that occurred in the process of
transferring the ﬂies into the 5 mm tubes.
Repeated measures ANOVA was used to deter-
mine signiﬁcant differences in activity between the
three treatment groups. Bonferroni’s multiple com-
parison tests versus control was used to measure
signiﬁcant differences in activity between the control
ﬂies and the lamotrigine fed ﬂies.
Fecundity assay
We evaluated age-speciﬁc fecundities using the same
dosing protocols as above, except that the ﬂies were
handled with one female and one male in each assay
vial. Fecundity was assayed from day 1 to 10 of adult
life. The number of eggs laid each day by each
individual female was recorded for this period of
10 days. The impact of drugs on fecundity was
assessed by a one-way ANOVA. We also compared
the 10-day fecundity of control females to the pooled
data from all three doses using a standard t-test on the
mean values.
Results
In our dose ﬁnding assays, we evaluated the impact of
a wide dosing range (1, 3, 6, 12, 24 and 48 mg/ml) of
lamotrigine onﬂymortality (data notshown).Forboth
males and females, lamotrigine treatment at 6 or
12 mg/ml resulted in statistically signiﬁcant decreases
inmortality(P\0.05forboth;conductedinduplicate
and triplicate, respectively) and 24 mg/ml of lamotri-
gine resulted in a statistically signiﬁcant decrease in
mortality for females only (P\0.05; conducted in
duplicate) (Fig. 1). Lamotrigine was found to be toxic
in both males and females at 48 mg/ml. Since 6 and
12 mg/ml of lamotrigine resulted in the highest
mortality reduction in both male and female ﬂies,
these doses were chosen to conduct the lifespan assay.
Lamotrigine increased mean lifespan in males and
females at both 6 and 12 mg/ml, and it increased
maximum lifespan in males and females at 12 mg/ml
(Fig. 2). At 6 mg/ml, mean lifespan was increased by
2.6 days (12.0%) in males (P\0.05) and 3.1 days
(12.8%) in females (P\0.05). At 12 mg/ml, mean
and maximum lifespan in males were increased by
3.3 days (15.4%) and 6.5 days, respectively; and in
females by 4.2 days (17.2%) and 6.3 days, respec-
tively (P\0.01, P\0.001 for mean increases).
To determine if the observed reduction in mortality
was a direct effect of lamotrigine treatment or due to a
secondary physiological effect caused by drug-
induced physiological changes, we examined meta-
bolic rates following lamotrigine treatment. We found
Fig. 1 The effect of lamotrigine on mortality rate at 0, 6, 12
and 24 mg/ml. The bars display SEM. * P\0.01, **
P\0.001
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males and females (Fig. 3). When comparing controls
with combined lamotrigine treatment arms, we found
that treated males showed a statistically signiﬁcant
depression in metabolic rate (P\0.05) and treated
females displayed a trend towards a metabolic rate
depression (P = 0.23).
Lamotrigine supplemented ﬂies showed a decrease
in locomotor activity at week one and four of feeding.
At week one, 6 mg/ml treatment resulted in a 7%
reduction in locomotion in males and a 15%
reduction in females (P\0.05 for both). At week
one, 12 mg/ml treatment caused a 55% decrease in
locomotor activity in females only (P\0.001). At
week four, 6 and 12 mg/ml decreased locomotion in
males by 32 and 29%, respectively (P\0.001,
P\0.0001). At week four, both 6 and 12 mg/ml
caused a 27% reduction in locomotion in females
(P\0.01 for both) (Fig. 4).
It was found that lamotrigine did not impact
fecundity, as no signiﬁcant differences existed
between control ﬂies compared to treated ﬂies (P\
0.703).
Discussion
In our study, the anticonvulsive lamotrigine increased
mean and maximum lifespan in male and female
Drosophila, but compromised the ﬂy health span, as
revealed by a signiﬁcant decrease in locomotion and
a trend towards a depression in metabolic rate.
Further, lamotrigine was not found to affect ﬂy
fecundity.
Although there are limited studies on anticonvul-
sants and aging, one report provided evidence that
ethosuximide or trimethadione, two commonly pre-
scribed anticonvulsants, increased mean and max-
imum life-span of C. elegans (Evason et al. 2005).
Fig. 2 The effect of
lamotrigine on the lifespan
of female (a) and male (b)
ﬂies. In both sexes,
lamotrigine resulted in a
signiﬁcant increase in mean
lifespan at six (P\0.05)
and 12 mg/ml (P\0.01)
and increased maximum
lifespan at 12 mg/ml
(P\0.001). Values on the
table are means ± SEM
and units are days
Fig. 3 The impact of 0, 6, 12 and 24 mg/ml of lamotrigine on
metabolic rate of adult male and female ﬂies. No statistically
signiﬁcant differences were observed. The bars display SEM
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threshold calcium currents in thalamic neurons,
which is consistent with their anticonvulsant actions
in absence seizures (Coulter et al. 1989). Since most
anticonvulsants act as mood stabilizers they may shift
C. elegans toward a dauer-like state—a semi-dor-
mant, quiescent state where C. elegans decrease their
metabolic rate in response to environmental stresses.
Therefore, the increased lifespan observed with
ethosuximide- and trimethadione-treatment may be
due to a decreased metabolic rate.
Lamotrigine anticonvulsive activity is thought to
occur through the inhibition of sodium channels,
hindering the release of glutamate and aspartate from
the axon terminal of neurons (Lang et al. 1993).
These neurotransmitters have been implicated in
a wide range of physiological functions, such as
learning and memory, metabolic processes, and the
regulation of respiration, among others (Rock 1968;
Fagg and Foster 1983; Wroblewski and Danysz 1989;
Advokat and Pellegrin 1992; Navarro et al. 1998;
Burton and Kazemi 2000). The trend in metabolic
rate depression that we observed in this study could
be due to lamotrigine inhibitory effect on glutamate
and aspartate and their roles in respiratory regulation.
Although this speciﬁc mechanistic hypothesis was
not tested in our study, we propose that the neuro-
transmitters’ effect on respiration and their ultimate
effect on the metabolic rate could have resulted in
lamotrigine-induced life span extension.
It has long been established that reduced metabolic
rates can increase poikilotherm life spans. This has
been demonstrated in C. elegans and house ﬂies
exposed to low temperatures, as well as house ﬂies
restricted in activity through the prevention of ﬂight
(Ragland and Sohal 1975; Klass 1977; Yan and Sohal
2000). Complementary studies have also shown that
increasing the metabolism of honeybees and kestrels
results in a decrease in life span (Wolf and Schmid-
Hempel 1989; Daan et al. 1996). In spite of these
earlier observations, a recent work reported no
correlation between longevity and metabolic rate in
Fig. 4 The effect of
lamotrigine on the
locomotor activity of
1 week old male ﬂies (a),
4 weeks old male ﬂies (b),
1 week old female ﬂies (c),
and 4 weeks old female
ﬂies (d). * P\0.05, **
P\0.01, *** P\0.001
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2003).
Since caloric restriction has been consistently
found to increase longevity in mammals and inver-
tebrates, there is the bare possibility that the presence
of lamotrigine in the food may induce lower levels of
food consumption. This could, in effect, mimic an
effect similar to dietary restriction. It is well estab-
lished that grossly depressed fecundity is associated
with dietary restriction sufﬁcient to signiﬁcantly
increase Drosophila longevity (Chippendale et al.
1993). In order to test for possible caloric restriction
effects in lamotrigine-supplemented Drosophila,w e
measured the number of eggs produced over a 10 day
period, ﬁnding no signiﬁcant differences in repro-
ductive output when treating with lamotrigine. Since
egg production is proportional to food level, the
absence of a decline in fecundity indicates that
the Drosophila females were not lowering their
levels of lamotrigine-supplemented food consump-
tion (Chapman and Partridge 1996). Additionally, the
dietary restriction enhancement of longevity observed
by Chippendale et al. (1993)using the same type of
stock of fruit ﬂies as those used here, required a
several-fold reduction in fecundity, we concluded
that the extension of life-span which we have
observed is not due to a dietary restriction effect
mediated by reduced fecundity. Thus, it appears that
the effect of lamotrigine on the longevity of adult
ﬂies was not mediated solely through effects on some
aspect(s) of reproduction.
Since agingis deﬁned by a number of physiological
and behavioral changes across the lifespan of an
organism, anti-aging compounds should increase life-
span without compromising health span. The associ-
ation between locomotor activity and aging has been
established in a variety of species. A lamotrigine-
induced decrease in locomotion is consistent with
previous studies. Atweek one,6 mg/mloflamotrigine
resulted in a 7% reduction in locomotion in males and
15% in females (P\0.05) and 12 mg/ml caused a
55% decrease in locomotor activity in females only
(P\0.001). These observations are consistent with
the ﬁnding that the performance of female ﬂies
declines more rapidly with aging (Le Bourg 2004).
At week four, 6 and 12 mg/ml decreased locomotion
in males and females to a comparable extent (27–
32%). The signiﬁcant reduction in locomotion at
weeks one and four suggest that anti-aging effects of
lamotrigine are associated with compromised func-
tion, and in this sense a reduced health span.
In conclusion, the observed decrease in mortality
and increase in lifespan as a result of lamotrigine was
associated with depression in locomotion and meta-
bolic rate, without a reduction in fecundity. Our
results suggest that assessing appropriate indicators
of health span is critical in the course of identifying
and discovering anti-aging compounds.
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